| Anna Saber Wagner, DO | |
|
4811 S Arrowhead Dr, Independence, MO 64055-6981 | |
| (816) 356-5000 | |
| (913) 495-3742 |
| Full Name | Anna Saber Wagner |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 28 Years |
| Location | 4811 S Arrowhead Dr, Independence, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912990003 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 110502 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centerpoint Medical Center | Independence, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Encompass Medical Group Pa | 0143116053 | 51 |
| Select Physical Therapy Holdings Inc | 9537076401 | 1487 |
News Archive
The Walter Reed Army Institute of Research this week administered the first vaccine in a Phase 1 clinical trial to evaluate the safety and immunogenicity of a Marburg vaccine candidate in healthy adult volunteers.
Sunovion Pharmaceuticals Inc. today announced that the New Drug Application (NDA) submitted for ciclesonide nasal aerosol in a hydrofluoroalkane (HFA) formulation has been accepted by the U.S. Food and Drug Administration.
The study published in the journal Science in October 2009, which found an association between the illness and a mouse leukemia retrovirus known as XMRV, was retracted last week by the editors of the journal.
For a promising pathway to treating Alzheimer's patients, "aim here." That's what National Institute of Standards of Technology researchers advised collaborators hunting for molecules that, by linking to a normally occurring enzyme, rev up the brain's capacity for clearing cholesterol-a boost associated with improvements in memory and other benefits in animal studies.
› Verified 4 days ago
| Entity Name | Encompass Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063457299 PECOS PAC ID: 0143116053 Enrollment ID: O20040226000869 |
News Archive
The Walter Reed Army Institute of Research this week administered the first vaccine in a Phase 1 clinical trial to evaluate the safety and immunogenicity of a Marburg vaccine candidate in healthy adult volunteers.
Sunovion Pharmaceuticals Inc. today announced that the New Drug Application (NDA) submitted for ciclesonide nasal aerosol in a hydrofluoroalkane (HFA) formulation has been accepted by the U.S. Food and Drug Administration.
The study published in the journal Science in October 2009, which found an association between the illness and a mouse leukemia retrovirus known as XMRV, was retracted last week by the editors of the journal.
For a promising pathway to treating Alzheimer's patients, "aim here." That's what National Institute of Standards of Technology researchers advised collaborators hunting for molecules that, by linking to a normally occurring enzyme, rev up the brain's capacity for clearing cholesterol-a boost associated with improvements in memory and other benefits in animal studies.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anna Saber Wagner, DO 8550 Marshall Dr Ste 220, Lenexa, KS 66214-1505 Ph: (816) 356-5000 | Anna Saber Wagner, DO 4811 S Arrowhead Dr, Independence, MO 64055-6981 Ph: (816) 356-5000 |
News Archive
The Walter Reed Army Institute of Research this week administered the first vaccine in a Phase 1 clinical trial to evaluate the safety and immunogenicity of a Marburg vaccine candidate in healthy adult volunteers.
Sunovion Pharmaceuticals Inc. today announced that the New Drug Application (NDA) submitted for ciclesonide nasal aerosol in a hydrofluoroalkane (HFA) formulation has been accepted by the U.S. Food and Drug Administration.
The study published in the journal Science in October 2009, which found an association between the illness and a mouse leukemia retrovirus known as XMRV, was retracted last week by the editors of the journal.
For a promising pathway to treating Alzheimer's patients, "aim here." That's what National Institute of Standards of Technology researchers advised collaborators hunting for molecules that, by linking to a normally occurring enzyme, rev up the brain's capacity for clearing cholesterol-a boost associated with improvements in memory and other benefits in animal studies.
› Verified 4 days ago
Dr. Michael G Wells, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11605 E 23rd St S, Independence, MO 64050 Phone: 816-579-6891 | |
Dr. Lewis Rosenblatt, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4621 S Shrank Dr, Suite B, Independence, MO 64055 Phone: 816-229-3200 Fax: 816-503-8325 | |
Katherine Field, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 19600 E 39th St S, Independence, MO 64057 Phone: 913-222-9779 Fax: 816-312-4380 | |
Ho Lau, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 19600 E 39th St S, Independence, MO 64057 Phone: 913-222-9779 Fax: 816-312-4380 | |
Dr. Janet Eileen Morgan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1520 E 23rd St, Suite I, Independence, MO 64055 Phone: 816-836-4740 Fax: 816-836-4745 | |
Jennifer J Patterson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4721 S Cliff Ave, Suite 200, Independence, MO 64055 Phone: 816-503-3700 Fax: 816-503-3704 | |
Katherine Suzanne Lee, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12400 E Us Highway 40, Independence, MO 64055 Phone: 816-890-9507 Fax: 816-890-9516 |